IQVIA Holdings Boosts FY26 Outlook; Shares Surge 10.6% - Update
IQVIA Holdings reported Q2 results and raised its FY2026 guidance. The company now expects adjusted earnings of $12.80 to $13.00 per share and revenue of $17.275 billion to $17.475 billion, citing stronger organic growth and updated M&A and FX impacts. Shares were up about 10.6% to $236.04 premarket.
How this was made

The 30-second read
Why it matters
The updated FY26 ranges provide a concrete basis to revise consensus estimates and valuation models, supporting continued trading volatility around the guidance.
Market read
A same-day guidance raise with specific numeric ranges is a direct catalyst for forward earnings expectations and near-term positioning.
What to watch
Traders will likely focus on whether the raised ranges reflect durable demand versus timing effects, and how much of the EPS uplift is attributable to non-organic items.
Background
IQV reported Q2 results and simultaneously updated its full-year 2026 adjusted earnings and revenue guidance ranges.
Ticker impact
IQV raised FY26 adjusted EPS guidance to $12.80-$13.00 and revenue to $17.275B-$17.475B, citing stronger organic growth and M&A/FX impacts.
Near-term upside bias likely persists as traders reprice FY26 estimates, though follow-through depends on whether the raised ranges beat consensus.
The article provides specific updated FY26 ranges and notes the company’s rationale (organic growth plus M&A/FX), which is actionable for forward-model adjustments.
Market effects
A guidance raise from a large life sciences services provider can modestly support sentiment for the broader CRO/life-sciences services complex.
Primarily US-listed sentiment impact via NYSE pre-market repricing.
Limited, unless peers interpret the organic growth strength as a broader demand signal.
Counterpoint
The guidance change may be partially driven by M&A and FX effects, so organic growth strength may be less bullish than the headline implies.
Key entities
- companyIQVIA Holdings Inc.
Raised FY26 adjusted EPS guidance to $12.80-$13.00 and revenue to $17.275B-$17.475B, citing stronger organic growth plus M&A and FX impacts.


